These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 10622058

  • 1. Non-inpatient use of teicoplanin.
    Nathwani D.
    Int J Clin Pract; 1998; 52(8):577-81. PubMed ID: 10622058
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A, Palau E, Puerro M, Vargas E, Picazo JJ.
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
    Török ME, Chapman AL, Lessing MP, Sanderson F, Seaton RA.
    Curr Opin Investig Drugs; 2010 Aug; 11(8):929-39. PubMed ID: 20721835
    [Abstract] [Full Text] [Related]

  • 10. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D.
    Medicina (B Aires); 2002 Aug; 62 Suppl 2():48-51. PubMed ID: 12481489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
    You JH, Lee GC, So RK, Cheung KW, Hui M.
    Infection; 2007 Jun; 35(4):265-70. PubMed ID: 17646907
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of glycopeptide antibiotics.
    Finch RG, Eliopoulos GM.
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii5-13. PubMed ID: 15750036
    [Abstract] [Full Text] [Related]

  • 20. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C, Fisher DA, Sklar GE, Li SC.
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.